Europe: Court awards compensation to Acteon for nullity proceedings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Europe: Court awards compensation to Acteon for nullity proceedings

In a recent ruling by the Court of The Hague (ECLI:NL:RBDHA:2018: 4591) a defendant/patentee has been ordered to pay the costs of nullity proceedings brought against it, despite not wishing to maintain or assert its patent.

Following infringement proceedings instituted in Germany by Dürr Dental based on European patent EP 1 9292 371 B1 against Acteon, the latter company, active in the same field, started nullity proceedings in the Netherlands against the Dutch part of this patent. Instead of providing arguments against the nullity attacks, Dürr Dental said that it had been, and still was, willing to withdraw the Dutch part of the patent. However, due to the pending proceedings, withdrawal of the patent was not possible anymore without the consent of Acteon. Acteon refused to give this. On the basis of this alleged lack of collaboration on the part of Acteon, Dürr Dental argued that Acteon had to bear the costs of the proceedings, brought without a preliminary warning and considered avoidable by Dürr Dental, and that Article 1019h Rv was not applicable in this case.

As a reminder, Article 1019h Rv provides for a reimbursement of costs by the losing party in IP cases. However, case law stipulates that this is not valid for nullity proceedings, except if the nullity proceedings are a defence against an infringement action or can be considered as a prospective defence of non-infringement.

In the absence of a defence, the Court revoked the Dutch part of the patent. With respect to the argument that the proceedings could have been avoided if Acteon had preliminarily warned Dürr Dental, the Court pointed to the fact that Dürr Dental had been paying annuities for several years to maintain the Dutch part of the patent. At the same time, the Court was of the opinion that in light of the infringement proceedings instituted by Dürr Dental in Germany, Acteon had rightfully started the Dutch nullity proceedings as a prospective defence of non-infringement. However, as Dürr Dental had immediately indicated that it did not wish to defend the Dutch part of its European patent, the Court ruled that only the costs incurred by Acteon until the writ was served, were to be borne by Dürr Dental.

Thus, even if a patentee indicates that it does not wish to exercise its patent rights, it can still be ordered to pay the costs of the proceedings.

Eva Eulaers

V.O.

Carnegieplein 5, 2517 KJ

The Hague

The Netherlands

Tel: +31 70 416 67 11

Fax: +31 70 416 67 99

info@vo.eu

www.vo.eu

more from across site and SHARED ros bottom lb

More from across our site

Hogan Lovells Cadwalader is taking a fresh strategic approach to pricing in its AI strategy. It could amplify calls for law firms to ditch the billable hour
Charles Harding plans to build a new team around life sciences oppositions and contentious work, drawing on his three decades developing a practice from scratch at D Young & Co
The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
The firm has tapped a local patent trio to establish a foothold in the market and broaden its national presence
New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
Gift this article